STOCK TITAN

Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences

The updated scope adds support for selected DevOps and AI-enabled capabilities within Gilead's technology environment.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
AI

Cognizant (CTSH) announced a five-year extension of its work with Gilead Sciences to support selected technology programs. The agreement expands support for DevOps, which combines software development and operations, and the responsible application of agentic AI tools. It follows more than a decade of work supporting elements of Gilead's IT infrastructure, platforms, applications and advanced analytics.

Loading...
Loading translation...

Positive

  • Minor pointFive-year extension with Gilead Sciences continues Cognizant's customer agreement for selected technology programs.
  • Minor pointExpanded scope adds support for selected DevOps and AI-enabled capabilities.

Negative

  • None.

Key Figures

Agreement term: Five years
Agreement term
Five years
Extension of Cognizant's work with Gilead

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Five-year agreement will support selected Gilead technology programs

TEANECK, N.J., Oct. 6, 2026 /PRNewswire/ -- Cognizant announced a five-year extension of its work with Gilead Sciences, a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades. Under the agreement, Cognizant will support Gilead's continued development of DevOps capabilities and the responsible application of agentic AI tools across selected technology programs.

Cognizant is an AI Builder company www.cognizant.ai

Cognizant will apply its life sciences and technology experience to support Gilead's development and operations environment. The work is expected to focus on practical use cases intended to simplify processes, improve delivery and help Gilead's teams execute priority technology programs more efficiently.

The agreement follows more than a decade of work in which Cognizant has supported elements of Gilead's global IT infrastructure, platforms, applications and advanced analytics. The updated scope will provide additional support for selected DevOps and AI-enabled capabilities as Gilead continues to strengthen the technology foundations that underpin its business and scientific priorities.

"Our focus is on giving our teams reliable, efficient technology that helps them move important work forward," said Anna Berg Asberg, Global CIO, Gilead. "This agreement provides additional support as we strengthen our DevOps capabilities and evaluate practical, responsible uses of AI across our technology environment—all in service of our broader mission to deliver for patients."

"We value the opportunity to continue supporting Gilead's technology priorities," said Surya Gummadi, President, Americas, Cognizant. "Our work will bring together life sciences experience, DevOps capabilities and AI tools to help Gilead improve delivery across selected programs."

"This agreement allows Cognizant to apply its technology capabilities and life sciences experience in support of Gilead's priorities," said Mohammad Haque, Global Head of Intelligent Enterprise Platforms & Large Deals, Cognizant. "The work will focus on practical tools and approaches designed to support operational efficiency and program execution."

About Cognizant
Cognizant is an AI Builder and technology services provider, building the bridge between AI investment and enterprise value by building full-stack AI solutions for our clients. Our deep industry, process and engineering expertise enables us to build an organization's unique context into technology systems that amplify human potential, realize tangible returns and keep global enterprises ahead in a fast-changing world. See how at www.cognizant.ai or @cognizant.

For more information, contact:

Natalie Steffen  
Natalie.Steffen@Cognizant.com

Cognizant is an AI Builder company www.cognizant.ai

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cognizant-expands-ai-enabled-devops-capabilities-for-gilead-sciences-302898819.html

SOURCE Cognizant Technology Solutions Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How long is Cognizant's extended agreement with Gilead Sciences?

Cognizant's agreement with Gilead Sciences is a five-year extension. It follows more than a decade of work supporting elements of Gilead's global IT infrastructure, platforms, applications and advanced analytics.

What work does Cognizant expect to focus on under the Gilead agreement?

Cognizant expects the work to focus on practical use cases intended to simplify processes, improve delivery and help Gilead's teams execute priority technology programs more efficiently.

Keep reading